Exact Mass: 401.02125720000004

Exact Mass Matches: 401.02125720000004

Found 62 metabolites which its exact mass value is equals to given mass value 401.02125720000004, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

5-Methyldeoxycytidine diphosphate

5-Methyldeoxycytidine 5-(trihydrogen diphosphate)

C10H17N3O10P2 (401.03891619999996)


   

Triasulfuron

Triasulfuron

C14H16ClN5O5S (401.0560636)


D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals

   

S-(1,2-Dichlorovinyl)glutathione

(2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[(E)-1,2-dichloroethenyl]sulfanyl}ethyl]-C-hydroxycarbonimidoyl}butanoic acid

C12H17Cl2N3O6S (401.0215082000001)


This compound belongs to the family of Peptides. These are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another.

   

Fenoldopam mesylate

Fenoldopam (mesylate)

C17H20ClNO6S (401.0699810000001)


D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Fenoldopam mesylate (SKF-82526) is a D1 receptor agonist and a novel lysine-specific demethylase 1 (LSD1) inhibitor (IC50=0.8974 μM). Fenoldopam mesylate shows anti-hypertensive effects, anti-cancer cell proliferation activity and can induce cells apoptosis[1][2][3].

   

4-(5-(4-Chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide

4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide

C16H11ClF3N3O2S (401.02125720000004)


D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors

   

S-(1,2-Dichlorovinyl)-glutathione

2-Amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(1,2-dichloroethenyl)sulphanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid

C12H17Cl2N3O6S (401.0215082000001)


   

5-Methanesulfonamido-6-(2,4-difluorothiophenyl)-1-indanone

N-{6-[2,4-bis(fluorosulfanyl)phenyl]-1-oxo-2,3-dihydro-1H-inden-5-yl}methanesulfonamide

C16H13F2NO3S3 (401.0025612)


D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors

   

Glutathione trisulfide

15-amino-10-(sulfanylmethyl)-1,5-dioxa-2,3,4-trithia-8,11-diazacyclohexadecane-6,9,12,16-tetrone

C10H15N3O6S4 (400.984369)


   
   

bemetizide

bemetizide

C15H16ClN3O4S2 (401.0270726)


C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic

   
   

1-Naphthalenesulfonicacid, 4-[2-(4-hydroxy-1-naphthalenyl)diazenyl]-, sodium salt (1:1)

1-Naphthalenesulfonicacid, 4-[2-(4-hydroxy-1-naphthalenyl)diazenyl]-, sodium salt (1:1)

C20H14N2NaO4S+ (401.05719440000007)


   

4-(3-BROMO-PHENYL)-2-(4-TERT-BUTYL-PHENOXYMETHYL)-THIAZOLE

4-(3-BROMO-PHENYL)-2-(4-TERT-BUTYL-PHENOXYMETHYL)-THIAZOLE

C20H20BrNOS (401.04488900000007)


   

penflutizide

penflutizide

C13H18F3N3O4S2 (401.0690784)


C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic

   

TERT-BUTYL 5-(BENZYLOXY)-3-BROMO-1H-INDOLE-1-CARBOXYLATE

TERT-BUTYL 5-(BENZYLOXY)-3-BROMO-1H-INDOLE-1-CARBOXYLATE

C20H20BrNO3 (401.0626470000001)


   

ETHYL 7-BROMO-1-CYCLOPROPYL-8-DIFLUOROMETHOXY-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXYLATE

ETHYL 7-BROMO-1-CYCLOPROPYL-8-DIFLUOROMETHOXY-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXYLATE

C16H14BrF2NO4 (401.0074208000001)


   

TERT-BUTYL 7-(BENZYLOXY)-3-BROMO-1H-INDOLE-1-CARBOXYLATE

TERT-BUTYL 7-(BENZYLOXY)-3-BROMO-1H-INDOLE-1-CARBOXYLATE

C20H20BrNO3 (401.0626470000001)


   

1-(TERT-BUTYL) 6-METHYL 3-IODO-1H-INDOLE-1,6-DICARBOXYLATE

1-(TERT-BUTYL) 6-METHYL 3-IODO-1H-INDOLE-1,6-DICARBOXYLATE

C15H16INO4 (401.0124046)


   

[4-(4-Amino-6-bromo-2-quinazolinyl)-1-piperazinyl]-2-furanylmethanone

[4-(4-Amino-6-bromo-2-quinazolinyl)-1-piperazinyl]-2-furanylmethanone

C17H16BrN5O2 (401.0487296)


   
   

trimethyl(2-naphthalen-2-yloxycarbonyloxyethyl)azanium,iodide

trimethyl(2-naphthalen-2-yloxycarbonyloxyethyl)azanium,iodide

C16H20INO3 (401.04878800000006)


   

clinafloxacin hydrochloride

clinafloxacin hydrochloride

C17H18Cl2FN3O3 (401.070919)


C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic

   
   

(3S)-(7-Bromo-2-oxo-5-pyridin-2-yl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-propionic acid Methyl ester

(3S)-(7-Bromo-2-oxo-5-pyridin-2-yl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-propionic acid Methyl ester

C18H16BrN3O3 (401.03749660000005)


   

Triflumidate

Triflumidate

C17H14F3NO5S (401.0544750000001)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   
   

N-(2,4,6-TRIMETHYLPHENYL)SULFONYL(4-IODO)ANILINE

N-(2,4,6-TRIMETHYLPHENYL)SULFONYL(4-IODO)ANILINE

C15H16INO2S (400.9946466)


   
   

disodium,3-[[4-(2-carboxylatoethylcarbamoyl)phenyl]hydrazinylidene]-6-oxocyclohexa-1,4-diene-1-carboxylate

disodium,3-[[4-(2-carboxylatoethylcarbamoyl)phenyl]hydrazinylidene]-6-oxocyclohexa-1,4-diene-1-carboxylate

C17H13N3Na2O6 (401.0599718)


   

4,4-(DIAZOAMINO)DIBENZENESULFONIC ACID DISODIUM SALT

4,4-(DIAZOAMINO)DIBENZENESULFONIC ACID DISODIUM SALT

C12H9N3Na2O6S2 (400.9728174)


   

Sofinicline benzenesulfonate

Sofinicline benzenesulfonate

C16H17Cl2N3O3S (401.0367632000001)


C78272 - Agent Affecting Nervous System > C47796 - Cholinergic Agonist > C73579 - Nicotinic Agonist

   

Uridine-diphosphate

Uridine-diphosphate

C9H11N2O12P2-3 (400.9787246)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

4-[1-(4-bromophenyl)-2-nitroethyl]-5-methyl-2-phenyl-1H-pyrazol-3-one

4-[1-(4-bromophenyl)-2-nitroethyl]-5-methyl-2-phenyl-1H-pyrazol-3-one

C18H16BrN3O3 (401.03749660000005)


   

2-[2-Amino-5-(2-bromophenoxy)pyrimidin-4-yl]-5-ethoxyphenol

2-[2-Amino-5-(2-bromophenoxy)pyrimidin-4-yl]-5-ethoxyphenol

C18H16BrN3O3 (401.03749660000005)


   

5-chloro-N-(2-(4-(2-oxopyridin-1(2H)-yl)benzamido)ethyl)thiophene-2-carboxamide

5-chloro-N-(2-(4-(2-oxopyridin-1(2H)-yl)benzamido)ethyl)thiophene-2-carboxamide

C19H16ClN3O3S (401.0600856000001)


   

N-Methyl-{4-[2-(7-oxo-6,7-dihydro-8H-[1,3]thiazolo[5,4-E]indol-8-ylidene)hydrazino]phenyl}methanesulfonamide

N-Methyl-{4-[2-(7-oxo-6,7-dihydro-8H-[1,3]thiazolo[5,4-E]indol-8-ylidene)hydrazino]phenyl}methanesulfonamide

C17H15N5O3S2 (401.061628)


   

grixazone A

grixazone A

C18H15N3O6S (401.06815300000005)


A cysteine derivative that is the S-(2-amino-8-formyl-3-oxo-3H-phenoxazin-1-yl) derivative of N-acetyl-L-cysteine.

   
   

2-amino-5-[[1-(carboxymethylamino)-3-[(Z)-1,2-dichloroethenyl]sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

2-amino-5-[[1-(carboxymethylamino)-3-[(Z)-1,2-dichloroethenyl]sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

C12H17Cl2N3O6S (401.0215082000001)


   

N-(3-methyl-4-nitro-1,2-oxazol-5-yl)-5-[2-methyl-5-(trifluoromethyl)pyrazol-3-yl]thiophene-2-carboxamide

N-(3-methyl-4-nitro-1,2-oxazol-5-yl)-5-[2-methyl-5-(trifluoromethyl)pyrazol-3-yl]thiophene-2-carboxamide

C14H10F3N5O4S (401.04055760000006)


   

(5Z)-1-(4-bromophenyl)-5-[(1,2,5-trimethylpyrrol-3-yl)methylidene]-1,3-diazinane-2,4,6-trione

(5Z)-1-(4-bromophenyl)-5-[(1,2,5-trimethylpyrrol-3-yl)methylidene]-1,3-diazinane-2,4,6-trione

C18H16BrN3O3 (401.03749660000005)


   

7-[[[5-(2,4-Dimethylanilino)-1,3,4-thiadiazol-2-yl]thio]methyl]-5-thiazolo[3,2-a]pyrimidinone

7-[[[5-(2,4-Dimethylanilino)-1,3,4-thiadiazol-2-yl]thio]methyl]-5-thiazolo[3,2-a]pyrimidinone

C17H15N5OS3 (401.04387)


   

2-[[5-(3-Chlorophenyl)-4-prop-2-enyl-1,2,4-triazol-3-yl]thio]-1-(3,4-dihydroxyphenyl)ethanone

2-[[5-(3-Chlorophenyl)-4-prop-2-enyl-1,2,4-triazol-3-yl]thio]-1-(3,4-dihydroxyphenyl)ethanone

C19H16ClN3O3S (401.0600856000001)


   

2-[(5-amino-1,3,4-thiadiazol-2-yl)thio]-N-[3-(diethylsulfamoyl)phenyl]acetamide

2-[(5-amino-1,3,4-thiadiazol-2-yl)thio]-N-[3-(diethylsulfamoyl)phenyl]acetamide

C14H19N5O3S3 (401.0649984)


   

N-(5-bromo-2-oxo-3-indolyl)-2-(2,6-dimethylphenoxy)acetohydrazide

N-(5-bromo-2-oxo-3-indolyl)-2-(2,6-dimethylphenoxy)acetohydrazide

C18H16BrN3O3 (401.03749660000005)


   

4-(2-bromo-4-methylphenyl)-3-[5-(2-furanyl)-1H-pyrazol-3-yl]-1H-1,2,4-triazole-5-thione

4-(2-bromo-4-methylphenyl)-3-[5-(2-furanyl)-1H-pyrazol-3-yl]-1H-1,2,4-triazole-5-thione

C16H12BrN5OS (400.9945882)


   

3-chloro-1-benzothiophene-2-carboxylic acid [2-oxo-2-(3-oxo-4H-1,4-benzoxazin-6-yl)ethyl] ester

3-chloro-1-benzothiophene-2-carboxylic acid [2-oxo-2-(3-oxo-4H-1,4-benzoxazin-6-yl)ethyl] ester

C19H12ClNO5S (401.01246920000006)


   

2-[[5-(2-methylanilino)-1,3,4-thiadiazol-2-yl]thio]-N-(2-nitrophenyl)acetamide

2-[[5-(2-methylanilino)-1,3,4-thiadiazol-2-yl]thio]-N-(2-nitrophenyl)acetamide

C17H15N5O3S2 (401.061628)


   
   

2-[(5E)-5-[(4-hydroxy-3-methoxyphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-2-phenylacetic acid

2-[(5E)-5-[(4-hydroxy-3-methoxyphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-2-phenylacetic acid

C19H15NO5S2 (401.03916200000003)


   

5-Methyldeoxycytidine 5-(trihydrogen diphosphate)

5-Methyldeoxycytidine 5-(trihydrogen diphosphate)

C10H17N3O10P2 (401.03891619999996)


   

UDP(3-)

UDP(3-)

C9H11N2O12P2 (400.9787246)


A nucleoside 5-diphosphate(3-) arising from deprotonation of the diphosphate OH groups of uridine 5-diphosphate (UDP); major species at pH 7.3.

   

DCVG

S-(1,2-Dichlorovinyl)glutathione

C12H17Cl2N3O6S (401.0215082000001)


   

Ribavirin 5-diphosphate(3-)

Ribavirin 5-diphosphate(3-)

C8H11N4O11P2 (400.98995759999997)


An organophosphate oxoanion resulting from the removal of the three diphosphate OH groups of ribavirin 5-diphosphate. It is the major species at pH 7.3.

   

3-[(2-amino-8-formyl-3-oxophenoxazin-1-yl)sulfanyl]-2-[(1-hydroxyethylidene)amino]propanoic acid

3-[(2-amino-8-formyl-3-oxophenoxazin-1-yl)sulfanyl]-2-[(1-hydroxyethylidene)amino]propanoic acid

C18H15N3O6S (401.06815300000005)


   

(2r)-3-[(2-amino-8-formyl-3-oxophenoxazin-1-yl)sulfanyl]-2-[(1-hydroxyethylidene)amino]propanoic acid

(2r)-3-[(2-amino-8-formyl-3-oxophenoxazin-1-yl)sulfanyl]-2-[(1-hydroxyethylidene)amino]propanoic acid

C18H15N3O6S (401.06815300000005)


   

6-[(2e,4e,6e,8e)-9-(3-bromo-1h-pyrrol-2-yl)nona-2,4,6,8-tetraen-2-yl]-4-methoxy-3-methylpyran-2-one

6-[(2e,4e,6e,8e)-9-(3-bromo-1h-pyrrol-2-yl)nona-2,4,6,8-tetraen-2-yl]-4-methoxy-3-methylpyran-2-one

C20H20BrNO3 (401.0626470000001)


   

6-[9-(3-bromo-1h-pyrrol-2-yl)nona-2,4,6,8-tetraen-2-yl]-4-methoxy-3-methylpyran-2-one

6-[9-(3-bromo-1h-pyrrol-2-yl)nona-2,4,6,8-tetraen-2-yl]-4-methoxy-3-methylpyran-2-one

C20H20BrNO3 (401.0626470000001)


   

[hydroxy([(2r,3s,5r)-3-hydroxy-5-(2-hydroxy-4-imino-5-methylpyrimidin-1-yl)oxolan-2-yl]methoxy)phosphoryl]oxyphosphonic acid

[hydroxy([(2r,3s,5r)-3-hydroxy-5-(2-hydroxy-4-imino-5-methylpyrimidin-1-yl)oxolan-2-yl]methoxy)phosphoryl]oxyphosphonic acid

C10H17N3O10P2 (401.03891619999996)